FDA Orders Cuts To Sleep-Aid Dosages Over Car Crash Risks

Law360, New York (January 10, 2013, 2:57 PM EST) -- The U.S. Food and Drug Administration on Thursday directed Sanofi-Aventis US LLC and other makers of insomnia drugs containing zolpidem to halve the recommended dosage for women, saying the increased drowsiness they may feel the morning after usage could make driving dangerous.

The agency is requiring drugmakers to lower the recommended dosage on labeling for Ambien and other bedtime-use, zolpidem-containing drugs from 10 milligrams to 5 mg for women taking immediate-release versions and from 12.5 to 6.25 mg for women taking extended-release versions. The labeling should...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.